Bruno Giordani.

Carole L. Marcus, M http://www.edmdrx.com .B., B.Ch. Moore, Ph.D., Carol L. Rosen, M.D., Bruno Giordani, Ph.D., Susan L. Garetz, M.D., H. Gerry Taylor, Ph.D., Ron B. Mitchell, M.D., Raouf Amin, M.D., Eliot S. Katz, M.D., Raanan Arens, M.D., Shalini Paruthi, M.D., Hiren Muzumdar, M.D., David Gozal, M.D., Nina Hattiangadi Thomas, Ph.D., Janice Ware, Ph.D., Dean Beebe, Ph.D., Karen Snyder, M.S., Lisa Elden, M.D., Robert C. Sprecher, M.D., Paul Willging, M.D., Dwight Jones, M.D., John P. Bent, M.D., Timothy Hoban, M.D., Ronald D. Chervin, M.D., Susan S. Ellenberg, Ph.D., and Susan Redline, M.D., M.P.H. For the Childhood Adenotonsillectomy Trial : A Randomized Trial of Adenotonsillectomy for Childhood Sleep Apnea The childhood obstructive sleep apnea syndrome is associated with numerous adverse health outcomes, including cognitive and behavioral deficits.1 The most commonly identified risk aspect for the childhood obstructive sleep apnea syndrome is adenotonsillar hypertrophy.